Clinical impact of lenvatinib in patients with unresectable hepatocellular carcinoma who received sorafenib

BACKGROUND: Lenvatinib has been approved for use in the systemic treatment for unresectable hepatocellular carcinoma (HCC). This study aimed to investigate the efficacy and safety of lenvatinib in patients with unresectable HCC who received sorafenib. METHODS: A total of 40 patients who received len...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:PeerJ
Main Authors: Chen, Yen-Yang, Wang, Chih-Chi, Liu, Yueh-Wei, Li, Wei-Feng, Chen, Yen-Hao
Format: Artigo
Sprog:Inglês
Udgivet: PeerJ Inc. 2020
Fag:
Gastroenterology and Hepatology
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7668202/
https://ncbi.nlm.nih.gov/pubmed/33240675
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7717/peerj.10382
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker